Rapamycin (Figure 7D), PD1 inhibitor (Figure 7E), and rapamycin combined with PD1 inhibitor (Figure 7F) treatment significantly reduced shTox MC38 group tumor size compared with the shCK MC38 group (Figure 7C). This evidence concerns the gene PDCD1 and neoplasm.